Barbie launches first doll with Type-1 diabetes. She wears glucose monitor and insulin pump
Mattel
has unveiled a groundbreaking new addition to its iconic Fashionistas line: a
Barbie
doll with
type 1 diabetes
. Wearing a continuous
glucose monitor
(CGM) on her arm and an
insulin pump
on her waist, this new Barbie is stylish, strong, and a symbol of representation for millions of children living with diabetes.
The launch was made possible through a thoughtful collaboration with Breakthrough T1D, a leading diabetes organisation, ensuring the medical details were not only accurate but thoughtfully designed in Barbie's signature style. In photos shared by Barbie's official Instagram, the new doll proudly wears her CGM secured with heart-shaped tape — a realistic nod to the way many children wear their devices — and holds a pink phone displaying a glucose tracking app.
Her waist-mounted insulin pump is just as important, delivering insulin as needed — a lifeline for anyone managing type 1 diabetes, which occurs when the body stops producing insulin. The Barbie is dressed in a blue polka-dot dress, with light blue boots and a matching purse. The colour blue itself is a global symbol for diabetes awareness, and a deliberate detail meant to spark conversation and understanding.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
지금, 유니세프 팀 팔찌
유니세프
지금 기부하기
Undo
Barbie's Instagram account shared, 'The doll represents the incredible people living with T1D, and shows kids that a life with this condition is just as vibrant, fulfilling, and rich with possibilities.'
According to Krista Berger, Senior Vice President of Barbie and Global Head of Dolls, Barbie plays a powerful role in shaping how children perceive the world around them. By representing medical conditions like type 1 diabetes, the brand aims to ensure that more children can feel seen and included in the stories they create and the dolls they love.
View this post on Instagram
A post shared by Barbie (@barbie)
Internet reacts
The launch of the new Barbie with type 1 diabetes has sparked an emotional wave of reactions online. One 47-year-old shared how they were diagnosed at age eight and had waited a lifetime to see such representation. Another person recalled being diagnosed at six in 1979, a time when there was no awareness or understanding of T1D, and children often misunderstood the condition as contagious. For many, this new Barbie feels like a long-overdue symbol of inclusion. Parents expressed gratitude too, with one mentioning how their daughter with T1D would be thrilled to see a doll that reflects her reality. Even adults who were diagnosed as children said they now feel seen — and are eager to share this meaningful doll with their own kids.
Barbie's inclusivity
This isn't the first time Barbie has stepped up her inclusivity game. In the 1960s, Mattel introduced its first Black Barbie dolls, followed by Hispanic dolls in the 1980s. In recent years, Barbie has expanded into more diverse territory than ever before — now offering more than 175 different Fashionistas dolls featuring a wide range of skin tones, hair textures, eye colours, body types, and disabilities. The line includes a Barbie with vitiligo, one who is blind, another with Down syndrome, and others with prosthetic limbs, hearing aids, and wheelchairs..
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
35 minutes ago
- Time of India
Relief for patients as pvt hosps withhold suspension of cashless treatment under RGHS
Jaipur: The Rajasthan Alliance of Hospital Associations (RAHA)'s advisory committee, formed for ongoing policy dialogue with the state govt on the Rajasthan Government Health Scheme (RGHS), withheld the suspension of cashless treatment to RGHS beneficiaries after a meeting with senior health department officials Monday. Earlier, RAHA called for stopping cashless treatment from July 15 under RGHS, protesting non-payment of bills for seven months along with other demands related to RGHS. "We will continue to provide cashless treatment to the RGHS beneficiaries as we were doing earlier. We have taken this decision after cordial discussions with the health department officials today (Monday)," Major General Dr SC Pareek, convenor of the eight-member advisory committee of RAHA, told TOI. He said, "We had some issues related to pending payments, closure of the transaction management system (TMS) of hospitals, and treatment protocols. We also demanded our participation in the formulation of the future standard operating procedures regarding RGHS implementation. They (govt) have agreed to it. It was a cordial discussion for a sustainable solution benefiting patients and hospitals." A senior health department official said, "The meeting was held on a positive note to ensure patients continue getting cashless treatment under the RGHS scheme." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Đây có thể là thời điểm tốt nhất để giao dịch vàng trong 5 năm qua IC Markets Tìm hiểu thêm Undo One of the demands of the RAHA was the unblocking of TMS portals, by immediate reinstatement of TMS access for claims closed on minor technical grounds, allowing hospitals to resubmit or amend such cases. On this demand, the health department assured the RAHA committee to unblock the TMS access, and proceedings will be expedited following due process as mentioned in the scheme guidelines. Regarding the demand for pending bills, the health department said that a major portion of outstanding approved claims was released. RGHS will expedite further payments and try to clear remaining outstanding claims by March 31, 2025, by July 31, 2025. On the demand for timely payment of hospital bills against cashless treatment of patients under RGHS, the health department pointed out that RGHS strives to maintain a 45 to 60-day payment cycle subject to budget constraints, and efforts are being made to align the timeline with the standard settlement process. On the demand for the participation of RAHA in the formulation of SOPs, the health department said that the minimum document protocol (MDP) for various components is in the process of formulation. The various stakeholders, including the advisory committee (RAHA), will be consulted and will try to finalise within three months, adding that RGHS acknowledges the role of consultation and will have regular dialogue with the identified representatives of various stakeholders, including the empanelled private hospitals and pharmacies.
Time of India
35 minutes ago
- Time of India
IMA organizes vaccination campaign for doctors to raise awareness
Kochi: To create awareness about importance of vaccines at a time when there is an increase in communicable diseases, IMA Kochi has decided to hold a vaccination campaign for doctors and their family members. The aim is to spread the message among common people that vaccines are not harmful and can help improve quality of life. "As doctors, we dedicate ourselves to caring for others but often neglect our own health, especially when it comes to preventive measures. Adult vaccination against certain serious infections can be lifesaving," said IMA Kochi president Dr Jacob Abraham. He said communicable diseases are increasing in Kerala because public hygiene is deteriorating due to poor infrastructure development and population density. Vaccines to be provided include shingles vaccine, and influenza, pneumococcal, hepatitis A and HPV vaccines for the age group 9 to 26 years. "More recently, hepatitis A has become a threat due to sewage contamination of public water supply. Though the disease is mild in children, it can occasionally lead to liver failure and death in adults, especially those over 40 years of age. This too is a vaccine-preventable disease," said IMA Kerala research cell convener Dr Rajeev Jayadevan. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like 99 Tips for Your Retirement Once Your Portfolio Reaches £250,000 Fisher Investments UK Undo "While all of us are aware of the importance of vaccinating children against deadly diseases, we often forget that adults also die from certain vaccine-preventable diseases. Top among these are influenza and pneumococcal pneumonia, against which safe and effective vaccines are available and are universally recommended. This drive will help protect doctors who are at greater risk due to being exposed to infectious agents," added Jayadevan. Abraham said the vaccine drive will help remove apprehensions and scepticism regarding vaccines in the minds of common people. IMA will also hold a vaccination camp on July 27.
Time of India
38 minutes ago
- Time of India
WHO recommends Gilead's twice-yearly injection for HIV prevention
The World Health Organization on Monday recommended Gilead 's lenacapavir , a twice-yearly injection, as a tool to prevent HIV infection . The recommendation, issued at the International AIDS Conference in Kigali, Rwanda, comes nearly a month after the U.S. health regulator approved the drug, giving patients new hope of interrupting virus transmission. The twice-yearly injectable offers a long-acting alternative to daily oral pills and other shorter-acting options, reshaping the response to the disease especially among those who face challenges with daily adherence, stigma, or access to health care. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Elegant New Scooters For Seniors In 2024: The Prices May Surprise You Mobility Scooter | Search Ads Learn More Undo "While an HIV vaccine remains elusive, lenacapavir is the next best thing," said Tedros Adhanom Ghebreyesus , WHO Director-General. The WHO's recommendations come at a critical moment as HIV prevention efforts stagnate with 1.3 million new HIV infections occurring in 2024 as funding challenges, stigma around the disease persist. Live Events These infections disproportionately impact populations such as sex workers, men who have sex with men, transgender people, people who inject drugs, people in prisons, and children and adolescents. WHO has also recommended a public health approach to HIV testing using HIV rapid tests that would remove a major access barrier by eliminating complex and costly procedures. Lenacapavir, part of a class of drugs known as capsid inhibitors, proved nearly 100% effective at preventing HIV in large trials last year.
